H00117581-M01

Singh M, Venugopal C, Tokar T, Brown KR, McFarlane N, Bakhshinyan D, Vijayakumar T, Manoranjan B, Mahendram S, Vora P, Qazi M, Dhillon M, Tong A, Durrer K, Murty N, Hallet R, Hassell JA, Kaplan DR, Cutz JC, Jurisica I, Moffat J, Singh SK
Acta neuropathologica 2017 Dec;134(6):923-940

Expression of Twist2 is controlled by T-cell receptor signaling and determines the survival and death of thymocytes.

Oh S, Oh J, Lee C, Oh S, Jeon S, Choi J, Hwang S, Lee Y, Lee H, Seong RH
Cell death and differentiation 2016 Nov 1;23(11):1804-1814

Epithelial-mesenchymal transition-like events in vulvar cancer and its relation with HPV.

Rodrigues IS, Lavorato-Rocha AM, de M Maia B, Stiepcich MM, de Carvalho FM, Baiocchi G, Soares FA, Rocha RM
British journal of cancer 2013 Jul 9;109(1):184-94

Twist2 is a valuable prognostic biomarker for colorectal cancer.

Yu H, Jin GZ, Liu K, Dong H, Yu H, Duan JC, Li Z, Dong W, Cong WM, Yang JH
World journal of gastroenterology 2013 Apr 21;19(15):2404-11

Significance of heterogeneous Twist2 expression in human breast cancers.

Mao Y, Zhang N, Xu J, Ding Z, Zong R, Liu Z
PloS one 2012;7(10):e48178

Evaluation of prognostic factors in stage IIA breast tumors and their correlation with mortality risk.

Carvalho ST, Stiepcich MM, Fregnani JH, Nonogaki S, Rocha R, Soares FA
Clinics (Sao Paulo, Brazil) 2011;66(4):607-12

Evaluation of prognostic factors in stage IIA breast tumors and their correlation with mortality risk.

Carvalho ST, Stiepcich MM, Fregnani JH, Nonogaki S, Rocha R, Soares FA
Clinics (Sao Paulo, Brazil) 2011;66(4):607-12

Discordant gene expression signatures and related phenotypic differences in lamin A- and A/C-related Hutchinson-Gilford progeria syndrome (HGPS).

Plasilova M, Chattopadhyay C, Ghosh A, Wenzel F, Demougin P, Noppen C, Schaub N, Szinnai G, Terracciano L, Heinimann K
PloS one 2011;6(6):e21433

Twist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewal.

Fang X, Cai Y, Liu J, Wang Z, Wu Q, Zhang Z, Yang CJ, Yuan L, Ouyang G
Oncogene 2011 Nov 24;30(47):4707-20

Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus.

Doreau A, Belot A, Bastid J, Riche B, Trescol-Biemont MC, Ranchin B, Fabien N, Cochat P, Pouteil-Noble C, Trolliet P, Durieu I, Tebib J, Kassai B, Ansieau S, Puisieux A, Eliaou JF, Bonnefoy-Bérard N
Nature immunology 2009 Jul;10(7):778-85

Molecular mechanism of transforming growth factor-beta-mediated inhibition of growth arrest and differentiation in a myoblast cell line.

Murakami M, Ohkuma M, Nakamura M
Development, growth & differentiation 2008 Feb;50(2):121-30

No comments: Submit comment

Supportive validation

Submitted by: Novus Biologicals (provider)
Main image
Experimental details: Western Blot: Twist-2 Antibody (3C8) [H00117581-M01] - Analysis of TWIST2 expression in transfected 293T cell line by TWIST2 monoclonal antibody (M01), clone 3C8.Lane 1: TWIST2 transfected lysate(18.1 KDa).Lane 2: Non-transfected lysate.

Supportive validation

Submitted by: Novus Biologicals (provider)
Main image
Experimental details: ELISA: Twist-2 Antibody (3C8) [H00117581-M01] - Detection limit for recombinant GST tagged TWIST2 is 0.3 ng/ml as a capture antibody.

Supportive validation

Submitted by: Novus Biologicals (provider)
Main image
Experimental details: Immunohistochemistry-Paraffin: Twist-2 Antibody (3C8) [H00117581-M01] - Immunoperoxidase of monoclonal antibody to TWIST2 ( Cat # H00117581-M01 ) on formalin-fixed paraffin-embedded human liver. [antibody concentration 3ug/ml]

Supportive validation

Submitted by: Novus Biologicals (provider)
Main image
Experimental details: Immunohistochemistry-Paraffin: Twist-2 Antibody (3C8) [H00117581-M01] - Analysis of monoclonal antibody to TWIST2 on formalin-fixed paraffin-embedded human adrenal gland. Antibody concentration 3 ug/ml.